UK markets closed

Deinove SA (DNVVF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.50000.0000 (0.00%)
At close: 10:18AM EST

Deinove SA

Cap Sigma
1682 rue de la Valsière ZAC Euromédecine II
Grabels 34790
France
33 4 48 19 01 00
https://www.deinove.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees44

Key executives

NameTitlePayExercisedYear born
Dr. Alexis RideauChief Exec. OfficerN/AN/AN/A
Prof. Miroslav Radman Ph.D.Co-Founder & Member of Scientific Advisory BoardN/AN/AN/A
Mr. Mario AlcarazChief Financial & Admin. OfficerN/AN/AN/A
Dr. Georges Gaudriault Ph.D.Chief Scientific OfficerN/AN/AN/A
Ms. Johane RinaldiChief HR OfficerN/AN/AN/A
Dr. Yannick Pletan M.D.Chief Medical Officer & Independent DirectorN/AN/AN/A
Mr. Michael Mourez Ph.D.Chief Innovation OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers PHYT-N-Resist, an anti-aging active ingredient for cosmetics; Luminity, a carotenoid-based ingredient to absorb blue light and exceptional antioxidant properties; HEBELYS, a natural active ingredient produced by fermentation of Sphingomonas; and BIOME Oléoactif, which acts as a post-biotic extract with a prebiotic effect to balance the skin microbiota. In addition, the company develops a process for producing natural ingredients for animal feed. DEINOVE SA has partnership agreements primarily with bioMérieux, Naicons, Medpace, Institut Pasteur, Hallstar Group, Sharon Laboratories, Oléos-Hallstar, Greentech, and Avril. The company was founded in 2006 and is headquartered in Grabels, France.

Corporate governance

Deinove SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.